Ethics top priority for US biotechnology, says retiring head
The retiring head of the US biotechnology association believes that ethics is the main issue which could derail his industry. “We have paid passionate attention to bioethics issues,” Carl Feldbaum told the Seattle Times. “We have taken them dead seriously. We have gone beyond narrow commercial interests and have tried to contribute, without commandeering, debates about Dolly, stem cells and gene therapy… The mishandling of a bioethics issue could derail us in no time, but hopefully that won’t happen.”
Latest posts by Mumbai (see all)
- Prescribe morning-after pills to young teenagers, say US pediatric group - November 30, 2012
- Bahrain sentences protest docs to prison - November 28, 2012
- Terry Pratchett assisted suicide documentary wins International Emmy - November 27, 2012
More Stories
Queen Elizabeth II’s forgotten link to the euthanasia debate
The death of Queen Elizabeth II on Thursday has dominated headlines for the last few days. BioEdge's editor was searching...
Should transphobic patients be given a ‘red card’?
Doctors and medical schools are being provided with detailed guidelines for accommodating the needs of transgender and gender-diverse medical students....
UK could revise standards for infant brain death after Baby A experience
Never simple, brain death in UK babies is being reviewed after a 3-month-old baby was declared “brain dead” due to...
Scotland and Uruguay: will they legalise euthanasia?
Two more countries are debating whether to legalise euthanasia: Scotland and Uruguay. In Scotland a Liberal Democrat member of the...
Dark cloud over celebrity surgeon in New Hampshire
The award-winning Boston Globe Spotlight team of investigative reporters has targeted a New Hampshire cardiothoracic surgeon. In a series of...
When did Hollywood actress Anne Heche really die?
After a fiery car crash on August 5, Anne Heche, a Hollywood actress who starred in TV shows and films...